Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION

PaperCitations, authors & open-access status

A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 166 citations, 1999 year and closed oa status.

166
Citations
1999
Year
closed
OA Status

Related on ScholarIQ

Bruce M. Hendry
Author
Transplantation
Journal
Renal Transplantation Outcomes and Treatments
Topic
Renal Transplantation Outcomes and Treatments
Topic
Cell Adhesion Molecules Research
Topic
Organ Transplantation Techniques and Outcomes
Topic
470M+ articles · free account